Home > News > pSivida signs licence with Beijing Med-Pharm
October 27th, 2005
pSivida signs licence with Beijing Med-Pharm
Abstract:
Global bio-nanotech company pSivida Limited is pleased to announce that it has signed a Licence with Beijing Med-Pharm Corporation for the clinical development, marketing and distribution of pSivida's lead product, BrachySilTM, in China.
Source:
biotech-intelligence.com
Bookmark:
| Related News Press |
Nanomedicine
Getting a better look at living cells April 25th, 2018
Biophysics -- lighting up DNA-based nanostructures April 25th, 2018
Remote-control shoots laser at nano-gold to turn on cancer-killing immune cells April 20th, 2018
Materials/Metamaterials
Getting electrons to move in a semiconductor: Gallium oxide shows high electron mobility, making it promising for better and cheaper devices April 24th, 2018
Organic solar cells reach record efficiency, benchmark for commercialization April 23rd, 2018
Salt boosts creation of 2-D materials: Rice University scientists show how salt lowers reaction temperatures to make novel materials April 18th, 2018
Individual impurity atoms detectable in graphene April 18th, 2018
Announcements
The dispute about the origins of terahertz photoresponse in graphene results in a draw April 26th, 2018
Getting a better look at living cells April 25th, 2018
Graphene origami as a mechanically tunable plasmonic structure for infrared detection April 25th, 2018
Nuclear radiation detecting device could lead to new homeland security tool: New device can detect gamma rays and identify radioactive isotopes April 25th, 2018
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||